CDKN2A and osteosarcoma: The genetic inactivation of the Rb pathway, including the deletion of CDK inhibitors p16INK4A and the pocket protein Rb, as well as amplification of CDK4, is part of the reason why osteosarcoma cells are able to avoid permanent cell-cycle exit.